J.O. Peabody
Henry Ford Health System
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J.O. Peabody.
European Urology Supplements | 2014
B. Varda; A. Sood; S. Marianne; K.R. Ghani; A. Rai; D. Pucheril; S.L. Chang; J.O. Peabody; Mani Menon; K. Olugbade; N. Ruhotina; J.D. Sammon; S. Sukumar; A.S. Kibel; K.C. Zorn; Q-D. Trinh
RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VTE by CRSs. The rates of VTEs and median times to VTE were 6% and 74 days in Group 1, 13% and 44 days in Group 2, 15% and 40 days in Group 3, and 23% and 11 days in Group 4. Adjusted hazard ratios for VTE are shown in Table 1. Group 1 had no VTE’s or fatal pulmonary embolisms in the first 30 days after UOS. Bleeding and lymphocele rates were 0% and 2% in Group 1, 0% and 4% in Group 2, 3% and 3% in Group 3, 0% and 0% in Group 4. Complications were considered Clavien grades II-IIIa. CONCLUSIONS: VTE risk is lowest in patients who receive clinical protocol prophylaxis with EDP. Risk of VTE remains elevated for at least 90 days following UOS. A clinical VTE prevention protocol using perioperative prophylaxis and EDP is effective and safe in reducing VTE risk in UOS patients.
European Urology Supplements | 2013
J.D. Sammon; K.R. Ghani; S. Sukumar; J.O. Peabody; Mani Menon; Q-D. Trinh
Purpose Previous studies examining the management of urinary tract infections (UTI) showed marked variability in the economical burden of care, with a tenfold increase in costs when patients require admission to the hospital. We sought to examine the patient and emergency department (ED) characteristics associated with hospitalization in patients presenting to the ED with UTI.
European Urology Supplements | 2012
Q-D. Trinh; Jesse D. Sammon; Marco Bianchi; K.R. Ghani; J. Jhaveri; W. Jeong; J. Schmitges; S. Sukumar; A. Dabaja; P.K. Agarwal; C.G. Rogers; J.O. Peabody; Mani Menon; Maxine Sun
European Urology Supplements | 2012
Jesse D. Sammon; Q-D. Trinh; K.R. Ghani; P. Ravi; S. Sukumar; J. Jhaveri; W. Jeong; P.K. Agarwal; C. Rogers; H. Stricker; J.O. Peabody; Mani Menon
European Urology Supplements | 2010
S. Sukumar; Mani Menon; J.O. Peabody; P.K. Agarwal
European Urology Supplements | 2015
F. Abdollah; D.E. Klett; A. Sood; J.D. Sammon; Q-D. Trinh; F. Montorsi; A. Briganti; J.O. Peabody; Pierre I. Karakiewicz; Mani Menon; M. Sun
European Urology Supplements | 2015
J.D. Sammon; A. Sood; F. Abdollah; D.E. Klett; M.H. Hayn; A.S. Kibel; J.O. Peabody; B. Varda; Mani Menon; Q-D. Trinh
European Urology Supplements | 2015
J.D. Sammon; D.E. Klett; A. Sood; F. Abdollah; D. Pucheril; M. Schmid; J. Hanske; C.P. Meyer; J.O. Peabody; Mani Menon; Q-D. Trinh
European Urology Supplements | 2015
A. Sood; F. Abdollah; J.D. Sammon; D.E. Klett; D. Pucheril; M. Schmid; J.O. Peabody; M.A. Preston; A.S. Kibel; Mani Menon; Q-D. Trinh
European Urology Supplements | 2015
A. Sood; J.D. Sammon; F. Abdollah; D.E. Klett; D. Pucheril; A.A. Friedman; J.O. Peabody; Mani Menon; Q-D. Trinh; J.S. Elder